Comments
The race to develop a Covid-19 vaccine is getting heated. Yesterday, Moderna announced that its RNA-based vaccine was 94.5 per cent effective in preventing the virus. Last week, Pfizer and BioNTech announced that their Covid vaccine was more than 90 per cent effective in the first results of the Phase 3 study. Here's a look at their trial progress, estimated capacities of vaccine manufacturers and more
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.